Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
7 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Pilot study of low-dose interleukin-2, pegylated interferon-alpha 2b, and ribavirin for the treatment of hepatitis C virus infection in patients with HIV infection.
J Infect Dis. 2005 Mar 1;191(5):686-93. doi: 10.1086/427812. Epub 2005 Jan 26.
J Infect Dis. 2005.
PMID: 15688281
Clinical Trial.
AIDS clinical trials group 5197: a placebo-controlled trial of immunization of HIV-1-infected persons with a replication-deficient adenovirus type 5 vaccine expressing the HIV-1 core protein.
Schooley RT, Spritzler J, Wang H, Lederman MM, Havlir D, Kuritzkes DR, Pollard R, Battaglia C, Robertson M, Mehrotra D, Casimiro D, Cox K, Schock B; AIDS Clinical Trials Group 5197 Study Team.
Schooley RT, et al.
J Infect Dis. 2010 Sep 1;202(5):705-16. doi: 10.1086/655468.
J Infect Dis. 2010.
PMID: 20662716
Free PMC article.
Clinical Trial.
Item in Clipboard
Virtual inhibitory quotient predicts response to ritonavir boosting of indinavir-based therapy in human immunodeficiency virus-infected patients with ongoing viremia.
Shulman N, Zolopa A, Havlir D, Hsu A, Renz C, Boller S, Jiang P, Rode R, Gallant J, Race E, Kempf DJ, Sun E.
Shulman N, et al.
Antimicrob Agents Chemother. 2002 Dec;46(12):3907-16. doi: 10.1128/AAC.46.12.3907-3916.2002.
Antimicrob Agents Chemother. 2002.
PMID: 12435695
Free PMC article.
Item in Clipboard
Sex-based outcomes of darunavir-ritonavir therapy: a single-group trial.
Currier J, Averitt Bridge D, Hagins D, Zorrilla CD, Feinberg J, Ryan R, Falcon R, Tennenberg A, Mrus J, Squires K; GRACE (Gender, Race, And Clinical Experience) Study Group.
Currier J, et al.
Ann Intern Med. 2010 Sep 21;153(6):349-57. doi: 10.7326/0003-4819-153-6-201009210-00002.
Ann Intern Med. 2010.
PMID: 20855799
Free PMC article.
Clinical Trial.
Item in Clipboard
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.
Eron JJ Jr, Park JG, Haubrich R, Aweeka F, Bastow B, Pakes GE, Yu S, Wu H, Richman DD; ACTG5126 Study Team.
Eron JJ Jr, et al.
Antimicrob Agents Chemother. 2009 Jun;53(6):2335-41. doi: 10.1128/AAC.01387-08. Epub 2009 Mar 23.
Antimicrob Agents Chemother. 2009.
PMID: 19307363
Free PMC article.
Clinical Trial.
Item in Clipboard
Focal mycobacterial lymphadenitis following initiation of protease-inhibitor therapy in patients with advanced HIV-1 disease.
Race EM, Adelson-Mitty J, Kriegel GR, Barlam TF, Reimann KA, Letvin NL, Japour AJ.
Race EM, et al.
Lancet. 1998 Jan 24;351(9098):252-5. doi: 10.1016/S0140-6736(97)04352-3.
Lancet. 1998.
PMID: 9457095
Item in Clipboard
Human immunodeficiency virus infection elicits early antibody not detected by standard tests: implications for diagnostics and viral immunology.
Race EM, Ramsey KM, Lucia HL, Cloyd MW.
Race EM, et al.
Virology. 1991 Oct;184(2):716-22. doi: 10.1016/0042-6822(91)90441-d.
Virology. 1991.
PMID: 1887591
Item in Clipboard
Cite
Cite